These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2161824)

  • 1. Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.
    Derouin F; Chastang C
    J Antimicrob Chemother; 1990 Apr; 25(4):708-11. PubMed ID: 2161824
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.
    Huskinson-Mark J; Araujo FG; Remington JS
    J Infect Dis; 1991 Jul; 164(1):170-1. PubMed ID: 1647421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
    Chang HR; Pechère JC
    Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii.
    Cantin L; Chamberland S
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1993-6. PubMed ID: 8239619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Toxoplasma gondii protein synthesis by azithromycin.
    Blais J; Garneau V; Chamberland S
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1701-3. PubMed ID: 8215287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.
    Fernandez-Martin J; Leport C; Morlat P; Meyohas MC; Chauvin JP; Vilde JL
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2049-52. PubMed ID: 1836943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
    Chang HR; Rudareanu FC; Pechère JC
    J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
    Ribeiro M; Franco PS; Lopes-Maria JB; Angeloni MB; Barbosa BF; Gomes AO; Castro AS; Silva RJD; Oliveira FC; Milian ICB; Martins-Filho OA; Ietta F; Mineo JR; Ferro EAV
    Exp Parasitol; 2017 Oct; 181():111-118. PubMed ID: 28803905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
    Mack DG; McLeod R
    Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
    Schoondermark-van de Ven E; Vree T; Melchers W; Camps W; Galama J
    Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
    Abugri DA; Witola WH; Russell AE; Troy RM
    Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii.
    Khan AA; Slifer TR; Araujo FG; Remington JS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):48-51. PubMed ID: 11120943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro.
    Derouin F; Santillana-Hayat M
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2575-7. PubMed ID: 10952623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.